About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Therapeutic Advances in Medical Oncology
›
Top Articles
Therapeutic Advances in Medical Oncology
Oncology
5.4
(top 2%)
Impact Factor
5.9
(top 2%)
extended IF
59
(top 7%)
H-Index
938
authors
922
papers
16.4K
citations
2.4K
citing journals
17K
citing authors
Most Cited Articles of Therapeutic Advances in Medical Oncology
Title
Year
Citations
An overview of the c-MET signaling pathway
2011
492
c-MET as a potential therapeutic target and biomarker in cancer
2011
261
Pharmacologic resistance in colorectal cancer: a review
2016
259
The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
2014
251
Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
2010
240
Targeting the Hedgehog pathway in cancer
2010
207
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
2018
202
Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma
2015
192
Circulating tumour cells: their utility in cancer management and predicting outcomes
2010
174
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
2016
167
CDK4/6 inhibition in breast cancer: current practice and future directions
2018
167
Nivolumab in NSCLC: latest evidence and clinical potential
2015
164
Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
2014
150
5-fluorouracil and cardiotoxicity: a review
2018
147
Predictive and prognostic molecular markers for cancer medicine
2010
138
Treatment of uveal melanoma: where are we now?
2018
136
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies
2014
135
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance
2019
129
Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients
2018
128
Health-related quality of life and cancer clinical trials
2011
127
Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects
2013
121
Radiation effects on antitumor immune responses: current perspectives and challenges
2018
118
Cancer-induced muscle wasting: latest findings in prevention and treatment
2017
112
Nivolumab in melanoma: latest evidence and clinical potential
2015
108
Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies
2015
104
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.